Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neutropenia in Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00035594
What this trial is testing

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

Who this might be right for
Neutropenia
Amgen 928
Large-scale testing (Phase 3)Study completedNCT00536081
What this trial is testing

Various G-CSF Regimens to Prevent Infection During Chemotherapy

Who this might be right for
Breast CancerChemotherapyFebrile Neutropenia
Academisch Ziekenhuis Maastricht 172
Post-approval studies (Phase 4)UnknownNCT01571518
What this trial is testing

Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

Who this might be right for
Neutropenia
Hyuk moon Kim 60
Post-approval studies (Phase 4)UnknownNCT02905916
What this trial is testing

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Who this might be right for
Mammary CancerLymphomaBone Tumour+1 more
Peking University 217
Testing effectiveness (Phase 2)Study completedNCT00115414
What this trial is testing

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Who this might be right for
Breast CancerFeverNeutropenia
Amgen
Large-scale testing (Phase 3)UnknownNCT03404752
What this trial is testing

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Who this might be right for
Breast Cancer
Gema Biotech S.A. 120
Testing effectiveness (Phase 2)UnknownNCT00501332
What this trial is testing

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Who this might be right for
Chemotherapy-Induced NeutropeniaBreast Cancer
Maxygen Holdings Ltd. 30
Large-scale testing (Phase 3)Study completedNCT02104830
What this trial is testing

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Who this might be right for
Chemotherapy-induced Neutropenia
Biocad 135
Large-scale testing (Phase 3)Study completedNCT02872103
What this trial is testing

Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 122
Not applicableNot Yet RecruitingNCT07806084
What this trial is testing

Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF

Who this might be right for
Breast CancerChemotherapy-Induced NeutropeniaFebrile Neutropenia+1 more
The First Affiliated Hospital with Nanjing Medical University 132
Post-approval studies (Phase 4)Study completedNCT02816164
What this trial is testing

Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 324
Large-scale testing (Phase 3)UnknownNCT03294577
What this trial is testing

Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 221
Early research (Phase 1)Study completedNCT04187898
What this trial is testing

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Who this might be right for
NeutropeniaBreast Cancer
Spectrum Pharmaceuticals, Inc 59
Early research (Phase 1)Study completedNCT00002866
What this trial is testing

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerNeutropenia
NCIC Clinical Trials Group 50
Not applicableStudy completedNCT02921191
What this trial is testing

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Who this might be right for
Breast CancerLung Cancer
Biologics & Biosimilars Collective Intelligence Consortium 57,725
Large-scale testing (Phase 3)Study completedNCT02467868
What this trial is testing

Efficacy and Safety Study With MYL-1401H and Neulasta

Who this might be right for
Breast NeoplasmsChemotherapy-Induced Febrile Neutropenia
Mylan Inc. 193
Large-scale testing (Phase 3)Study completedNCT02643420
What this trial is testing

SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)

Who this might be right for
NeutropeniaBreast Cancer
Spectrum Pharmaceuticals, Inc 406
Post-approval studies (Phase 4)Study completedNCT02805153
What this trial is testing

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

Who this might be right for
Breast Cancer
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 215
Large-scale testing (Phase 3)Study completedNCT03252431
What this trial is testing

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 393
Testing effectiveness (Phase 2)UnknownNCT00555516
What this trial is testing

A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy

Who this might be right for
Breast CancerChemotherapyNeutropenia
Tri-Service General Hospital (TSGH) 60
Next Page